HEIDELBERG UNIVERSITY
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1386-01-01
- Employees
- -
- Market Cap
- -
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2005-06-23
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 30
- Registration Number
- NCT00115518
- Locations
- π©πͺ
University of Heidelberg, Heidelberg, Germany
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Phase 3
Completed
- Conditions
- Leukemia
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 1551
- Registration Number
- NCT00055874
- Locations
- π©πͺ
Kreiskrankenhaus Aurich, Aurich, Germany
π©πͺKrankenhaus / Klinikum Krefeld, Aachen, Germany
π©πͺHaematologisch-Onkologische Schwerpunktpraxis, Berlin, Germany
Β© Copyright 2025. All Rights Reserved by MedPath